{
    "2019-05-23": [
        [
            {
                "time": "2019-05-23",
                "original_text": "Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3",
                "features": {
                    "keywords": [
                        "Moody's",
                        "affirms",
                        "downgrades",
                        "GCCFC",
                        "2005-GG3"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-23",
                "original_text": "Next level of support for Pioneer? Pfizer or J&J? The viewers #AskHalftime",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "J&J",
                        "support"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-23",
                "original_text": "Alphabet to Aid Pharma Giants Enhance Clinical Trial Process",
                "features": {
                    "keywords": [
                        "Alphabet",
                        "Pharma",
                        "Clinical",
                        "Trial"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-23",
                "original_text": "Lilly (LLY) Launches Half-Priced Version of Humalog Insulin",
                "features": {
                    "keywords": [
                        "Lilly",
                        "LLY",
                        "Humalog",
                        "Insulin"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-23",
                "original_text": "Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "NVCN",
                        "IOVA",
                        "MDT",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-24",
                "original_text": "Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "JNJ",
                        "Ex-Dividend",
                        "Date"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}